George Scangos, CEO of Vir Biotechnology, talks with PE about his thoughts on building a culture of innovation. The former Biogen head also talks about his latest endeavor, a biotech start-up waging war on infectious disease.
Cover: Pharmaceutical Engineering talks with George Scangos, CEO of Vir Biotechnology, about his thoughts on building a culture of innovation. The former Biogen head also talks about his latest endeavor, a biotech start-up waging war on infectious disease.
Feature: First, a look at Singapore, a global hub for biopharma and a key player in the market. Next, Jim Breen and Kyran Johnson provide a tour of Janssen Pharmaceuticals’ Ringaskiddy, Ireland, expansion of its global manufacturing capacity for biologics that treat multiple myeloma, rheumatoid arthritis, and Crohn’s disease.
Special Section: A Special Section explores the amazing growth of ISPE’s Young Professional community from the first Young Professional event at the 2007 ISPE Annual Meeting to 2018. ISPE Young Professionals held over 60 events in 15 countries this year, drawing more than 2,000 attendees.